NO20041595L - Ny kombinasjon bestaende av en PDE4 inhibitor eller en PDE3/4 inhibitor i kombinasjon med en leukotrienreseptorantagonist for behandling av luftveislidelser - Google Patents

Ny kombinasjon bestaende av en PDE4 inhibitor eller en PDE3/4 inhibitor i kombinasjon med en leukotrienreseptorantagonist for behandling av luftveislidelser

Info

Publication number
NO20041595L
NO20041595L NO20041595A NO20041595A NO20041595L NO 20041595 L NO20041595 L NO 20041595L NO 20041595 A NO20041595 A NO 20041595A NO 20041595 A NO20041595 A NO 20041595A NO 20041595 L NO20041595 L NO 20041595L
Authority
NO
Norway
Prior art keywords
inhibitor
combination
pde3
treatment
receptor antagonist
Prior art date
Application number
NO20041595A
Other languages
English (en)
Other versions
NO331885B1 (no
Inventor
Rolf Beume
Daniela Bundschuh
Christian Weimar
Stefan-Lutz Wollin
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of NO20041595L publication Critical patent/NO20041595L/no
Publication of NO331885B1 publication Critical patent/NO331885B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20041595A 2001-09-19 2004-04-19 Farmasoytisk sammensetning, produkt og kit omfattende en PDE4-inhibitor og en leukotrienreseptorantagonist samt anvendelser derav og en fremgangsmate for fremstilling av sammensetningen. NO331885B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01000474 2001-09-19
PCT/EP2002/010423 WO2003024488A2 (en) 2001-09-19 2002-09-17 Combination of a pde inhibitor and a leukotriene receptor antagonist

Publications (2)

Publication Number Publication Date
NO20041595L true NO20041595L (no) 2004-06-16
NO331885B1 NO331885B1 (no) 2012-04-30

Family

ID=8176066

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041595A NO331885B1 (no) 2001-09-19 2004-04-19 Farmasoytisk sammensetning, produkt og kit omfattende en PDE4-inhibitor og en leukotrienreseptorantagonist samt anvendelser derav og en fremgangsmate for fremstilling av sammensetningen.

Country Status (26)

Country Link
US (1) US20050014762A1 (no)
EP (1) EP1429843B1 (no)
JP (1) JP2005505570A (no)
KR (1) KR20040044946A (no)
CN (1) CN100346831C (no)
AT (1) ATE349243T1 (no)
BR (1) BR0212582A (no)
CA (1) CA2460442A1 (no)
CO (1) CO5560584A2 (no)
CY (1) CY1106365T1 (no)
DE (1) DE60217139T2 (no)
DK (1) DK1429843T3 (no)
EA (1) EA007736B1 (no)
ES (1) ES2279004T3 (no)
HK (1) HK1066752A1 (no)
HU (1) HUP0500078A3 (no)
IL (2) IL160272A0 (no)
MA (1) MA27136A1 (no)
MX (1) MXPA04002560A (no)
NO (1) NO331885B1 (no)
NZ (1) NZ532279A (no)
PL (1) PL205927B1 (no)
PT (1) PT1429843E (no)
SI (1) SI1429843T1 (no)
WO (1) WO2003024488A2 (no)
ZA (1) ZA200402653B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719518D0 (en) * 2007-10-05 2007-11-14 Therapeutics Ltd E Therapy
WO2009052624A1 (en) * 2007-10-25 2009-04-30 Merck Frosst Canada Ltd. Combination therapy
WO2012168907A1 (en) 2011-06-10 2012-12-13 Glenmark Pharmaceuticals Sa Pharmaceutical composition comprising revamilast and montelukast or zafirlukast
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
PE20151332A1 (es) 2013-02-19 2015-09-20 Pfizer Compuestos de azabencimidazol
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
US20160339010A1 (en) 2014-01-22 2016-11-24 Takeda Gmbh Treatment of Partly Controlled or Uncontrolled Severe Asthma
JP6713982B2 (ja) 2014-07-24 2020-06-24 ファイザー・インク ピラゾロピリミジン化合物
DK3177624T3 (da) 2014-08-06 2019-07-01 Pfizer Imidazopyridazinforbindelser

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028986A1 (es) * 1999-02-23 2003-06-04 Smithkline Beecham Corp USO DE UN INHIBIDOR DE PDE4 EN LA FABRICACIoN DE UNA PREPARACIoN DE LIBERACIoN CONTROLADA; FORMULACION DE LIBERACION CONTROLADA PARA EL TRATAMIENTO DE COPD, UN PROCEDIMIENTO PARA SU PREPARACIoN Y COMPOSICIoN FARMACÉUTICA
EA006685B1 (ru) * 1999-08-21 2006-02-24 Алтана Фарма Аг Синергетическая композиция
MY134008A (en) * 1999-12-22 2007-11-30 Merck Frosst Canada Inc Subtituted 8-arylquinoline phospohodiestrase-4 inhibitors
MXPA02007419A (es) * 2000-01-31 2002-12-09 Pfizer Prod Inc Derivados de nicotinamida benzocondensada-heterociclilo utiles como inhibidores selectivos de las isozimas pde4.
MY123585A (en) * 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
AU6196201A (en) * 2000-05-25 2001-12-03 Merck Frosst Canada Inc Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor

Also Published As

Publication number Publication date
HK1066752A1 (en) 2005-04-01
WO2003024488A2 (en) 2003-03-27
US20050014762A1 (en) 2005-01-20
PL367414A1 (en) 2005-02-21
WO2003024488A3 (en) 2003-09-04
NO331885B1 (no) 2012-04-30
DE60217139T2 (de) 2007-10-04
EP1429843A2 (en) 2004-06-23
KR20040044946A (ko) 2004-05-31
CO5560584A2 (es) 2005-09-30
PT1429843E (pt) 2007-03-30
CA2460442A1 (en) 2003-03-27
BR0212582A (pt) 2004-10-13
SI1429843T1 (sl) 2007-06-30
CY1106365T1 (el) 2011-10-12
HUP0500078A2 (hu) 2005-04-28
EP1429843B1 (en) 2006-12-27
ES2279004T3 (es) 2007-08-16
EA007736B1 (ru) 2006-12-29
EA200400416A1 (ru) 2004-12-30
MA27136A1 (fr) 2005-01-03
NZ532279A (en) 2006-02-24
ZA200402653B (en) 2005-02-14
ATE349243T1 (de) 2007-01-15
DE60217139D1 (de) 2007-02-08
CN100346831C (zh) 2007-11-07
HUP0500078A3 (en) 2010-07-28
MXPA04002560A (es) 2004-05-31
JP2005505570A (ja) 2005-02-24
PL205927B1 (pl) 2010-06-30
IL160272A0 (en) 2004-07-25
IL160272A (en) 2008-03-20
CN1655846A (zh) 2005-08-17
DK1429843T3 (da) 2007-04-30

Similar Documents

Publication Publication Date Title
ATE340796T1 (de) Dihydropyrrolo(1,2-aöindol- und tetrahydropyrido)1,2-aöindolderivate als prostaglandin rezeptor antagonisten
UY28958A1 (es) Nuevos derivados de piridazin-3(2h)-ona
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
CY2013041I1 (el) Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων
BRPI0418112A (pt) inibidores de p-38 quinase bicìclico heterocìclicos
ATE479686T1 (de) Pyridopyrrolizin- und pyridoindolizinderivate
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
CY1106927T1 (el) Φαρμακευτικη συνθεση ενος pde4 ή pde3/4 αναστολεα και ανταγωνιστη υποδοχεα ισταμινης
CY1106365T1 (el) Συνδυασμος ενος αναστολεα pde και ενος ανταγωνιστη υποδοχεων λευκοτριενιου
EE200400042A (et) 8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena
NO20034232D0 (no) Anvendelse av glukokortikoid-reseptor-spesifikke antagonister ved behandling av stresslidelser
MA27539A1 (fr) Nouvelle combinaison synergique contenant du roflumilast et du formoterol
IL198759A (en) Use of 3gal receptor antagonists to prepare medications to treat depression and / or anxiety
ATE266420T1 (de) Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält
TW200621261A (en) Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
ME00549B (me) Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja
BR0000486A (pt) Antagonistas do neuropeptìdeo y
BR9910696A (pt) Composições farmacêuticas
NO20026085L (no) Ny anvendelse av angiotensin II antagonister
PT1448566E (pt) Antagonistas do receptor quimioquina e metodos de utilizacao do mesmo
NO20002538L (no) Deteksjon av pusteforstyrrelser

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

MM1K Lapsed by not paying the annual fees